Thioridazine Stimulates Prolactin Secretion in Man
- 1 July 1975
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 32 (7) , 885-886
- https://doi.org/10.1001/archpsyc.1975.01760250077008
Abstract
Thioridazine, unlike most other effective antipsychotic drugs, appears to be only a weak dopamine antagonist in various regions of the brain. We decided to test, indirectly, thioridazine's effects on another brain dopaminergic system, the tuberoinfundibular tract, which regulates prolactin secretion by stimulating hypothalamic secretion of prolactin-inhibiting factor. Chlorpromazine and several other phenothiazines have been shown to stimulate prolactin secretion. Five healthy men ingested 50 mg of chlorpromazine concentrate on one occasion, and 50 mg of thioridazine concentrate on another. Both drugs noticeably stimulated prolactin secretion within two hours. It is concluded that thioridazine is a potent dopamine antagonist in the tuberoinfundibular system, and it is suggested that this system's regulation of prolactin secretion may provide a useful method for studying antipsychotic drug effects in man.Keywords
This publication has 8 references indexed in Scilit:
- Antischizophrenic Drugs and Brain Cholinergic ReceptorsArchives of General Psychiatry, 1974
- Anti-muscarinic properties of neuroleptics and drug-induced ParkinsonismNature, 1974
- Effects of Serotonin Precursors and Melatonin on Serum Prolactin Release in RatsEndocrinology, 1973
- Amphetamine Psychosis: A "Model" Schizophrenia Mediated by CatecholaminesAmerican Journal of Psychiatry, 1973
- CHLORPROMAZINE STIMULATION AND L-DOPA SUPPRESSION OF PLASMA PROLACTIN IN MAN1Journal of Clinical Endocrinology & Metabolism, 1971
- Effect of drugs used in psychoses on cerebral dopamine metabolismBritish Journal of Pharmacology, 1970
- Aminergic Systems in Basal Ganglia Associated with Stereotyped Hyperactive Behavior and CatalepsyBrain, Behavior and Evolution, 1968
- MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4‐DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5‐HYDROXYTRYPTAMINE IN THE BRAINBritish Journal of Pharmacology and Chemotherapy, 1965